{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:12Z","timestamp":1793187792760,"version":"4.5.0"},"reference-count":484,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"DOI":"10.1210\/er.2008-0030","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T03:07:15Z","timestamp":1233976035000},"page":"1-50","source":"Crossref","is-referenced-by-count":334,"title":["Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review"],"prefix":"10.1210","volume":"30","author":[{"given":"Stefano","family":"Palomba","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology (S.P., A.F., F.Z.), University \u201cMagna Graecia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Falbo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology (S.P., A.F., F.Z.), University \u201cMagna Graecia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Zullo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology (S.P., A.F., F.Z.), University \u201cMagna Graecia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Francesco","family":"Orio","sequence":"additional","affiliation":[{"name":"Endocrinology (F.O.), University \u201cParthenope\u201d of Naples, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2008,12,4]]},"reference":[{"key":"2019041121421313500_R1","first-page":"337","author":"Zawadzki","year":"1992"},{"key":"2019041121421313500_R2","first-page":"19","article-title":"consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014a common finding in normal women.","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"2019041121421313500_R4","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.","volume":"91","author":"Franks","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.","volume":"39","author":"Robinson","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R8","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R9","first-page":"995","article-title":"Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone agonist testing.","volume":"85","author":"Chang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligoamenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121421313500_R12","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/GCO.0b013e328307ebc5","article-title":"Insulin sensitizing agents and reproductive function in polycystic ovary syndrome patients.","volume":"20","author":"Palomba","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019041121421313500_R14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(02)03275-2","article-title":"Molecular progress in infertility: polycystic ovary syndrome.","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-992919","article-title":"Looking for polycystic ovary syndrome genes: rational and best strategy.","volume":"26","author":"Goodarzi","year":"2008","journal-title":"Semin Reprod Med"},{"key":"2019041121421313500_R16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R17","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041121421313500_R20","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc07-2190","article-title":"Metabolic phenotype in the brothers of women with polycystic ovary syndrome.","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jc.2007-1958","article-title":"Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.","volume":"93","author":"Kent","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R23","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/jc.2007-2256","article-title":"Metabolic profile in sons of women with polycystic ovary syndrome.","volume":"93","author":"Recabarren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.metabol.2007.08.010","article-title":"Evidence for pancreatic \u03b2-cell dysfunction in brothers of women with polycystic ovary syndrome.","volume":"57","author":"Sam","year":"2008","journal-title":"Metabolism"},{"key":"2019041121421313500_R25","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121421313500_R26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"2019041121421313500_R27","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.fertnstert.2006.05.035","article-title":"Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome.","volume":"86","author":"Palomba","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/humrep\/dei351","article-title":"Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.","volume":"21","author":"Palomba","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R29","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/humrep\/del267","article-title":"Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study.","volume":"21","author":"Palomba","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R30","author":"Lord","year":"2003"},{"key":"2019041121421313500_R31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncpendmet0787","article-title":"Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome\u2014a reappraisal.","volume":"4","author":"Dunaif","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121421313500_R32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"2019041121421313500_R33","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome: a position statement of the Androgen Excess Society.","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R34","first-page":"126","article-title":"American Association of Clinical Endocrinologists position statements on metabolic and cardiovascular consequences of polycystic ovary syndrome.","volume":"11","year":"2005","journal-title":"Endocr Pract"},{"key":"2019041121421313500_R35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome.","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.fertnstert.2008.04.073","article-title":"Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective.","volume":"90","author":"Nestler","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R37","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"2019041121421313500_R39","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/db07-0275","article-title":"Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.","volume":"56","author":"Skov","year":"2007","journal-title":"Diabetes"},{"key":"2019041121421313500_R41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)53510-9","article-title":"Dysregulation of cytochrome P450c 17\u03b1 as the cause of polycystic ovarian syndrome.","volume":"53","author":"Rosenfield","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R42","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","article-title":"Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations.","volume":"83","author":"Weil","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R43","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary.","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041121421313500_R44","first-page":"707","article-title":"Ovarian follicle atresia: a hormonally controlled apoptotic process.","volume":"15","author":"Hsueh","year":"1994","journal-title":"Endocr Rev"},{"key":"2019041121421313500_R45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R47","first-page":"346","article-title":"Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.","volume":"12","author":"Prager","year":"1986","journal-title":"Diabetes Metab"},{"key":"2019041121421313500_R48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2337\/diab.41.3.354","article-title":"Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.","volume":"41","author":"Widen","year":"1992","journal-title":"Diabetes"},{"key":"2019041121421313500_R49","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/0006-2952(88)90617-X","article-title":"Inhibition of hepatic gluconeogenesis by metformin: synergism with insulin.","volume":"37","author":"Wollen","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"2019041121421313500_R50","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin.","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0168-8227(93)90127-Q","article-title":"Biguanides may produce hypoglycemic action in isolated rat hepatocytes through their effects on L-alanine transport.","volume":"22","author":"Komori","year":"1993","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041121421313500_R52","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/diab.46.9.1406","article-title":"Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver.","volume":"46","author":"Radziuk","year":"1997","journal-title":"Diabetes"},{"key":"2019041121421313500_R53","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/diabetes.48.6.1251","article-title":"Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin.","volume":"48","author":"Large","year":"1999","journal-title":"Diabetes"},{"key":"2019041121421313500_R54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2826.2007.01643.x","article-title":"The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.","volume":"20","author":"Coyral-Castel","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"2019041121421313500_R55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1095\/biolreprod.106.055749","article-title":"Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5\u2032 monophosphate-activated protein kinase (AMPK).","volume":"76","author":"Tosca","year":"2007","journal-title":"Biol Reprod"},{"key":"2019041121421313500_R56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1095\/biolreprod.106.050831","article-title":"Metformin-induced stimulation of adenosine 5\u2032 monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells.","volume":"75","author":"Tosca","year":"2006","journal-title":"Biol Reprod"},{"key":"2019041121421313500_R57","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action.","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"2019041121421313500_R58","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1432-1033.1993.tb17886.x","article-title":"Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.","volume":"213","author":"Argaud","year":"1993","journal-title":"Eur J Biochem"},{"key":"2019041121421313500_R59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"2019041121421313500_R60","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP activated protein kinase by the anti-diabetic drug metformin in vivo.","volume":"279","author":"Zou","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041121421313500_R61","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"2019041121421313500_R62","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/molehr\/gal057","article-title":"The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice.","volume":"12","author":"Elia","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"2019041121421313500_R63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-2952(01)00679-7","article-title":"Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes.","volume":"62","author":"Fulgencio","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"2019041121421313500_R64","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI116005","article-title":"Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.","volume":"90","author":"Sarabia","year":"1992","journal-title":"J Clin Invest"},{"key":"2019041121421313500_R65","first-page":"S34","article-title":"Evidence that metformin increases insulin-stimulated glucose transport by potentiating insulin-induced translocation of glucose transporters from an intracellular pool to the cell surface in rat adipocytes","volume":"26","author":"Matthaei","year":"1992","journal-title":"Horm Metab Res"},{"key":"2019041121421313500_R66","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/EJE-07-0857","article-title":"Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.","volume":"158","author":"Jensterle","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-199958001-00008","article-title":"Pathogenesis of type 2 diabetes: implications for metformin.","volume":"58","author":"DeFronzo","year":"1999","journal-title":"Drugs"},{"key":"2019041121421313500_R68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2337\/diacare.10.1.62","article-title":"Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.","volume":"10","author":"Nosadini","year":"1987","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R69","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/diab.40.7.850","article-title":"Association of metformin\u2019s effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes.","volume":"40","author":"Matthaei","year":"1991","journal-title":"Diabetes"},{"key":"2019041121421313500_R70","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/BF00873219","article-title":"Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes.","volume":"29","author":"Jacobs","year":"1986","journal-title":"Diabetologia"},{"key":"2019041121421313500_R71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/endo.137.1.8536601","article-title":"Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle.","volume":"137","author":"Dominguez","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121421313500_R72","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/endo.137.7.8770923","article-title":"The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes.","volume":"137","author":"Stith","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121421313500_R73","first-page":"274","article-title":"Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes.","volume":"21","author":"Santos","year":"1995","journal-title":"Diabete Metab"},{"key":"2019041121421313500_R74","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diacare.13.6.696","article-title":"Cellular mechanism of action of metformin.","volume":"13","author":"Klip","year":"1990","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/joe.0.1420245","article-title":"Internalization of metformin is necessary for its action on potentiating the insulin-induced Xenopus laevis oocyte maturation.","volume":"142","author":"Khan","year":"1994","journal-title":"J Endocrinol"},{"key":"2019041121421313500_R76","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1210\/endo.131.3.1505458","article-title":"Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.","volume":"131","author":"Hundal","year":"1992","journal-title":"Endocrinology"},{"key":"2019041121421313500_R77","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1440-1681.1993.tb01742.x","article-title":"Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin dependent diabetic patients and effects of metformin.","volume":"20","author":"Yoa","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2019041121421313500_R78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/endo.136.2.7835271","article-title":"Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats.","volume":"136","author":"Fischer","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121421313500_R79","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/diab.42.8.1159","article-title":"Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes.","volume":"42","author":"Kozka","year":"1993","journal-title":"Diabetes"},{"key":"2019041121421313500_R80","first-page":"212","article-title":"Effect of metformin on glucose metabolism in mouse soleus muscle.","volume":"12","author":"Bailey","year":"1986","journal-title":"Diabete Metab"},{"key":"2019041121421313500_R81","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3\u03b2-hydroxysteroid dehydrogenase.","volume":"276","author":"Arlt","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041121421313500_R82","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis.","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells.","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R84","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R85","first-page":"4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17\u03b1 activity and serum androgens.","volume":"82","author":"Nestler","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R86","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jcem-70-4-894","article-title":"The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.","volume":"70","author":"Erickson","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R87","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fertnstert.2005.04.043","article-title":"Metformin alters insulin signaling and viability of human granulosa cells.","volume":"84","author":"Sonnatag","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R88","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(99)00407-0","article-title":"Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome.","volume":"72","author":"Marca","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R89","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/09513590500476164","article-title":"Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.","volume":"22","author":"Genazzani","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R90","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.fertnstert.2005.09.065","article-title":"Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system.","volume":"85","author":"Budak","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R91","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","article-title":"Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence","volume":"86","author":"Barb","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2019041121421313500_R92","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors.","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"2019041121421313500_R93","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003495-199549050-00007","article-title":"Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.","volume":"49","author":"Dunn","year":"1995","journal-title":"Drugs"},{"key":"2019041121421313500_R94","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1124\/dmd.107.020180","article-title":"Mechanisms underlying saturable intestinal absorption of metformin.","volume":"36","author":"Proctor","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"2019041121421313500_R95","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/pd.2026","article-title":"Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model.","volume":"28","author":"Kovo","year":"2008","journal-title":"Prenat Diagn"},{"key":"2019041121421313500_R96","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.fertnstert.2004.11.051","article-title":"Placental passage of metformin in women with polycystic ovary syndrome.","volume":"83","author":"Vanky","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R97","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9378(97)70541-6","article-title":"Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin.","volume":"176","author":"Elliott","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14740338.6.2.191","article-title":"Metformin before and during pregnancy and lactation in polycystic ovary syndrome.","volume":"6","author":"Glueck","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"2019041121421313500_R99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2362.1994.tb02257.x","article-title":"Reduction of the acute bioavailability of metformin by the \u03b1-glucosidase inhibitor acarbose in normal man.","volume":"24","author":"Scheen","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"2019041121421313500_R100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2125.1987.tb03090.x","article-title":"Reduction of metformin renal tubular secretion by cimetidine in man.","volume":"23","author":"Somogyi","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"2019041121421313500_R101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/14622416.9.4.415","article-title":"Polymorphism in human organic cation transporters and metformin action.","volume":"9","author":"Takane","year":"2008","journal-title":"Pharmacogenomics"},{"key":"2019041121421313500_R102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/147323000803600116","article-title":"Functional involvement of the organic cation transporter 2 (rOct2) in the renal uptake of organic cations in rats.","volume":"36","author":"Umehara","year":"2008","journal-title":"J Int Med Res"},{"key":"2019041121421313500_R103","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2008.61","article-title":"Genetic variants of the organic cation transporter 2 influence the disposition of metformin.","volume":"84","author":"Song","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"2019041121421313500_R104","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","article-title":"Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.","volume":"103","author":"Garber","year":"1997","journal-title":"Am J Med"},{"key":"2019041121421313500_R105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome.","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome.","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R107","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/00912700122010546","article-title":"Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers.","volume":"41","author":"Gusler","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"2019041121421313500_R108","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0149-2918(03)80093-0","article-title":"Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.","volume":"25","author":"Fujioka","year":"2003","journal-title":"Clin Ther"},{"key":"2019041121421313500_R109","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1742-1241.2008.01733.x","article-title":"The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.","volume":"62","author":"Gao","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2019041121421313500_R110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R111","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.","volume":"90","author":"Harborne","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R112","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2007-1009","article-title":"Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome.","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R113","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/humrep\/deg105","article-title":"Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial.","volume":"18","author":"George","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R114","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/humrep\/deh248","article-title":"Metformin treatment before IVF\/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double-blind study.","volume":"19","author":"Kj\u00f8tr\u00f8d","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R115","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R116","first-page":"3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.","volume":"85","author":"Ibanez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R117","author":"Palomba","year":"26 2008"},{"key":"2019041121421313500_R118","author":"Palomba","year":"7 2008"},{"key":"2019041121421313500_R119","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.","volume":"90","author":"Palomba","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R120","author":"Zain","year":"5 2008"},{"key":"2019041121421313500_R121","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial.","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"key":"2019041121421313500_R122","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-3659(00)00374-6","article-title":"Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation.","volume":"71","author":"Stepensky","year":"2001","journal-title":"J Control Release"},{"key":"2019041121421313500_R123","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial.","volume":"16","author":"Ng","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R124","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial.","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial.","volume":"17","author":"Yarali","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R126","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R127"},{"key":"2019041121421313500_R128","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/archinte.163.21.2594","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.","volume":"163","author":"Salpeter","year":"2003","journal-title":"Arch Intern Med"},{"key":"2019041121421313500_R129","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/diacare.21.10.1659","article-title":"Lactic acidosis rates in type 2 diabetes.","volume":"21","author":"Brown","year":"1998","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bmj.326.7379.4","article-title":"Contraindications to the use of metformin.","volume":"326","author":"Jones","year":"2003","journal-title":"BMJ"},{"key":"2019041121421313500_R131","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5694\/j.1326-5377.2008.tb01713.x","article-title":"Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.","volume":"188","author":"Kamber","year":"2008","journal-title":"Med J Aust"},{"key":"2019041121421313500_R132","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-2008-1065319","article-title":"Prevalence of risk determinants for metformin-associated lactic acidosis and metformin utilization in the study of health in Pomerania.","volume":"40","author":"Runge","year":"2008","journal-title":"Horm Metab Res"},{"key":"2019041121421313500_R133","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1752-1947-1-126","article-title":"Metformin-induced lactic acidosis: a case series.","volume":"1","author":"Silvestre","year":"2007","journal-title":"J Med Case Reports"},{"key":"2019041121421313500_R134","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1463-1326.2006.00657.x","article-title":"Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?","volume":"10","author":"Runge","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2019041121421313500_R135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1464-5491.2008.02411.x","article-title":"Establishing pragmatic estimated glomerular filtration rate thresholds to guide metformin prescribing: careful assessment of risks and benefits is required.","volume":"25","author":"George","year":"2008","journal-title":"Diabet Med"},{"key":"2019041121421313500_R136","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/15563650701355314","article-title":"Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.","volume":"46","author":"Audia","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"2019041121421313500_R137","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1017\/S026502150700097X","article-title":"Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity.","volume":"25","author":"Jain","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"2019041121421313500_R138","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.333.7569.653-a","article-title":"Acute renal failure from contrast medium: beware patients taking metformin.","volume":"333","author":"Sayer","year":"2006","journal-title":"BMJ"},{"key":"2019041121421313500_R139","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9343(98)00088-6","article-title":"Metformin-induced acute hepatitis.","volume":"104","author":"Babich","year":"1998","journal-title":"Am J Med"},{"key":"2019041121421313500_R140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11096-008-9218-3","article-title":"Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.","volume":"30","author":"Laporte","year":"2008","journal-title":"Pharm World Sci"},{"key":"2019041121421313500_R141","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT).","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R142","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2006.02.030","article-title":"Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.","volume":"536","author":"Cortizo","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2019041121421313500_R143","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study.","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R144","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/01443610600831266","article-title":"Acute alopecia due to metformin treatment for polycystic ovarian syndrome.","volume":"26","author":"Jothilakshmi","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"2019041121421313500_R145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/humupd\/dmi015","article-title":"Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.","volume":"11","author":"Checa","year":"2005","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R146","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes.","volume":"358","author":"Rowan","year":"2008","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R147","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01221950","article-title":"Metformin in management of pregnant insulin independent diabetes.","volume":"16","author":"Coetzee","year":"1979","journal-title":"Diabetologia"},{"key":"2019041121421313500_R148","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-8227(86)80036-5","article-title":"The management of non-insulin-dependent diabetes during pregnancy","volume":"1","author":"Coetzee","year":"1985","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041121421313500_R149","first-page":"171","article-title":"Metformin use during the first trimester of pregnancy. Is it safe?","volume":"52","author":"Koren","year":"2006","journal-title":"Can Fam Physician"},{"key":"2019041121421313500_R150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis.","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R151","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.fertnstert.2005.09.047","article-title":"Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.","volume":"85","author":"Thatcher","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R152","author":"Bolton","year":"7 2008"},{"key":"2019041121421313500_R153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmm034","article-title":"Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.","volume":"14","author":"Fauser","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R154","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.","volume":"157","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.","volume":"28","author":"Yilmaz","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2019041121421313500_R156","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09513590701192529","article-title":"Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity.","volume":"23","author":"Marcondes","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R157","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R158","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.","volume":"81","author":"Maciel","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R159","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2005.05.010","article-title":"Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?","volume":"123","author":"Onalan","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121421313500_R161","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09513590701214398","article-title":"Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.","volume":"23","author":"Genazzani","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R162","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2007-1736","article-title":"Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene.","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R163","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1472-6483(10)60809-7","article-title":"Metformin monotherapy in lean women with polycystic ovary syndrome.","volume":"10","author":"Kumari","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"2019041121421313500_R164","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.fertnstert.2006.11.133","article-title":"Comparison of two doses of metformin (2.5 and 1.5 g\/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference.","volume":"88","author":"Bruno","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R165","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2005-1994","article-title":"Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial.","volume":"91","author":"Eisenhardt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R166","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1701-2163(16)32202-2","article-title":"Use of metformin for ovulation induction in women who have polycystic ovary syndrome with or without evidence of insulin resistance.","volume":"28","author":"Liu","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"key":"2019041121421313500_R167","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R168","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/den182","article-title":"Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?","volume":"23","author":"Moll","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R169","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/met.2004.2.192","article-title":"Effect of metaformin in Asian Indian women with polycystic ovarian syndrome","volume":"2","author":"Misra","year":"2004","journal-title":"Metab Syndr Relat Disord"},{"key":"2019041121421313500_R170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0015-0282(16)35047-6","article-title":"Clinical and biochemical features of polycystic ovarian disease","volume":"14","author":"Goldzieher","year":"1963","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R171","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0889-8529(18)30401-8","article-title":"Clinical manifestations of polycystic ovarian disease.","volume":"17","author":"Young","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121421313500_R172","first-page":"561","article-title":"Hyperandrogenism and uterine bleeding.","volume":"2","author":"Deaton","year":"1991","journal-title":"Infertil Reprod Med Clin North Am"},{"key":"2019041121421313500_R173","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(98)00141-1","article-title":"Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama.","volume":"70","author":"Azziz","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R174","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jcem-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism.","volume":"62","author":"Barbieri","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone binding globulin levels in obese women with the polycystic ovary syndrome.","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R176","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199608293350909","article-title":"Insulin and the polycystic ovary syndrome.","volume":"335","author":"Utiger","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R177","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2265.1999.00786.x","article-title":"The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.","volume":"51","author":"Unluhizarci","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R178","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).","volume":"29","author":"Glueck","year":"2001","journal-title":"J Adolesc Health"},{"key":"2019041121421313500_R179","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jcem.86.8.7756","article-title":"Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.","volume":"86","author":"Ibanez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R180","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R181","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R182","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R183","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol\u2013cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R184","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R185","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills.","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R186","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.","volume":"92","author":"Luque-Rami\u0301rez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R187","first-page":"3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R188","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","article-title":"Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.","volume":"13","author":"Dahlgren","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R189","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R190","author":"Costello","year":"2007"},{"key":"2019041121421313500_R191","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R192","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/humrep\/den095","article-title":"Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.","volume":"23","author":"Luque-Rami\u0301rez","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R193","first-page":"1","article-title":"Recent advances in medically assisted conception.","volume":"820","year":"1992","journal-title":"WHO Tech Rep Ser"},{"key":"2019041121421313500_R194","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.fertnstert.2006.06.050","article-title":"Utility of screening for other causes of infertility in women with \u201cknown\u201d polycystic ovary syndrome.","volume":"87","author":"McGovern","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R195","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.fertnstert.2007.11.041","article-title":"Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome.","volume":"90","author":"Al-Ozairi","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R196","first-page":"CD000056","article-title":"Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea","volume":"Rev","author":"Hughes","year":"2000","journal-title":"Cochrane Database Syst"},{"key":"2019041121421313500_R197","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1472-6483(10)60592-5","article-title":"Metformin use in infertile patients with polycystic ovary syndrome: an evidence-based overview.","volume":"16","author":"Palomba","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2019041121421313500_R198","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R199","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jcem.82.2.3727","article-title":"The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.","volume":"82","author":"Fulghesu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humrep\/13.3.567","article-title":"The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.","volume":"13","author":"Dale","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R201","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/deh609","article-title":"Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries.","volume":"20","author":"Rice","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.","volume":"79","author":"Costello","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R203","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis.","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"2019041121421313500_R204","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.","volume":"19","author":"Kashyap","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R205","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fertnstert.2006.06.014","article-title":"Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review.","volume":"86","author":"Siebert","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmm026","article-title":"The role of metformin in polycystic ovary syndrome: a systematic review.","volume":"13","author":"Moll","year":"2007","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R207","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of metformin in polycystic ovary syndrome: a meta-analysis.","volume":"111","author":"Creanga","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2019041121421313500_R208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/humupd\/dmm049","article-title":"Metformin in therapy naive patients with polycystic ovary syndrome.","volume":"14","author":"Palomba","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R209","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/09513590701414212","article-title":"What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered.","volume":"23","author":"Palomba","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R210","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome.","volume":"13","author":"Pasquali","year":"2006","journal-title":"BJOG"},{"key":"2019041121421313500_R211","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/humupd\/dmh018","article-title":"Improving reproductive performance in overweight\/obese women with effective weight management.","volume":"10","author":"Norman","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R212","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R213","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2006.07.1499","article-title":"Weight loss by bariatric surgery and subsequent fertility.","volume":"87","author":"Merhi","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R214","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1067\/mob.2003.459","article-title":"A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment.","volume":"188","author":"Branigan","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R215","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2007-1393","article-title":"Editorial: clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is.","volume":"92","author":"Barbieri","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R216","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.fertnstert.2007.05.034","article-title":"Triplet pregnancy after metformin in a woman with polycystic ovary syndrome.","volume":"89","author":"Clapauch","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R217","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1210\/jc.2008-0287","article-title":"Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome.","volume":"93","author":"Cataldo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R218","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone.","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R219","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2265.2005.02392.x","article-title":"Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome.","volume":"63","author":"Palomba","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R220","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.fertnstert.2007.09.004","article-title":"Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network\u2019s Pregnancy in Polycystic Ovary Syndrome Trial.","volume":"90","author":"McGovern","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R221","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/jc.2004-0689","article-title":"Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.","volume":"89","author":"Palomba","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R222","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1447-0756.2006.00401.x","article-title":"Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling.","volume":"32","author":"Kocak","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"2019041121421313500_R223","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0015-0282(01)02941-7","article-title":"Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.","volume":"77","author":"Kocak","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R224","author":"Sinawat","year":"2008"},{"key":"2019041121421313500_R225","author":"Palomba","year":"2009"},{"key":"2019041121421313500_R226","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/humrep\/del020","article-title":"Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease.","volume":"21","author":"Sohrabvand","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R227","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.fertnstert.2005.10.042","article-title":"Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.","volume":"85","author":"Khorram","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R228","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2125.2002.01575.x","article-title":"Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice.","volume":"53","author":"Sturrock","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"2019041121421313500_R229","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2005.04.004","article-title":"Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome.","volume":"90","author":"Hwu","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"2019041121421313500_R230","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome.","volume":"21","author":"Costello","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R231","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/humrep\/dei130","article-title":"A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.","volume":"20","author":"Palomba","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R232","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/eje.1.01866","article-title":"Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment.","volume":"152","author":"Santbrink","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R233","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R234","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/ENDO:30:1:27","article-title":"Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.","volume":"30","author":"Gorry","year":"2006","journal-title":"Endocrine"},{"key":"2019041121421313500_R235","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.fertnstert.2006.11.021","article-title":"Increase of multiple pregnancies caused by ovulation induction with gonadotropin in combination with metformin in infertile women with polycystic ovary syndrome.","volume":"87","author":"Shibahara","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R236","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1196\/annals.1434.004","article-title":"Pretreatments before the induction of ovulation in assisted reproduction technologies: evidence-based medicine in 2007.","volume":"1127","author":"Bromer","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"2019041121421313500_R237","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a138174","article-title":"Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.","volume":"8","author":"Balen","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R238","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.299.6698.541","article-title":"Influence of past reproductive performance on risk of spontaneous abortion.","volume":"299","author":"Regan","year":"1989","journal-title":"BMJ"},{"key":"2019041121421313500_R239","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/jc.2003-030975","article-title":"Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy.","volume":"89","author":"Jakubowicz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R240","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R241","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(87)90235-2","article-title":"Identification of placental protein 14 as an immunosuppressive factor in human reproduction.","volume":"1","author":"Bolton","year":"1987","journal-title":"Lancet"},{"key":"2019041121421313500_R242","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-0378(98)00018-7","article-title":"Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface.","volume":"39","author":"Giudice","year":"1998","journal-title":"J Reprod Immunol"},{"key":"2019041121421313500_R243","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","article-title":"Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis.","volume":"92","author":"Wood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R244","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R245","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R246","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome.","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R247","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.fertnstert.2005.09.063","article-title":"Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome.","volume":"85","author":"Palomba","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R248","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.04.021","article-title":"Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome.","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R249","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humrep\/deg190","article-title":"Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine.","volume":"18","author":"Schachter","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R251","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1210\/jc.2005-0965","article-title":"Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.","volume":"90","author":"Orio Jr","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R252","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1023\/A:1022523906655","article-title":"Epigenetic influences on oocyte developmental competence: perifollicular vascularity and intrafollicular oxygen.","volume":"15","author":"Van Blerkom","year":"1998","journal-title":"J Assist Reprod Genet"},{"key":"2019041121421313500_R253","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/humrep\/12.5.1047","article-title":"The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.","volume":"12","author":"Van Blerkom","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R254","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.fertnstert.2007.07.1385","article-title":"Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome.","volume":"90","author":"Wei","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R255","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fertnstert.2005.04.043","article-title":"Metformin alters insulin signaling and viability of human granulosa cells.","volume":"84","author":"Sonntag","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R256","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.2337\/db07-0074","article-title":"AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations.","volume":"56","author":"Eng","year":"2007","journal-title":"Diabetes"},{"key":"2019041121421313500_R257","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/endo.141.12.7816","article-title":"High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF-1 receptor.","volume":"141","author":"Chi","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121421313500_R258","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1507\/endocrj.40.413","article-title":"Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartments of polycystic ovaries.","volume":"40","author":"Samoto","year":"1993","journal-title":"Endocr J"},{"key":"2019041121421313500_R259","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/humrep\/17.2.457","article-title":"Preimplantation exposure to high insulin-like growth factor I concentrations results in increased resorption rates in vivo.","volume":"17","author":"Pinto","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R260","author":"Palomba","year":"2008"},{"key":"2019041121421313500_R261","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R262","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/09513590601010508","article-title":"Metformin reduces abortion in pregnant women with polycystic ovary syndrome.","volume":"22","author":"Khattab","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R263","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2007.06.079","article-title":"Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study.","volume":"90","author":"Zolghadri","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R264"},{"key":"2019041121421313500_R265"},{"key":"2019041121421313500_R266","first-page":"194","article-title":"Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.","volume":"94","author":"Radon","year":"1999","journal-title":"Obstet Gynecol"},{"key":"2019041121421313500_R267","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","article-title":"High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.","volume":"83","author":"Holte","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R268","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R269","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00001703-200406000-00007","article-title":"Should we continue or stop insulin sensitizing drugs during pregnancy?","volume":"16","author":"Norman","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019041121421313500_R270","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humrep\/deh109","article-title":"Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy.","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R271","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R272","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R273","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.fertnstert.2007.03.036","article-title":"Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.","volume":"89","author":"Glueck","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R274","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1464-5491.2000.00314.x","article-title":"Oral hypoglycaemic agents in 118 diabetic pregnancies.","volume":"17","author":"Hellmuth","year":"2000","journal-title":"Diabet Med"},{"key":"2019041121421313500_R275","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.2337\/dc07-s217","article-title":"Pharmacological management of gestational diabetes: an overview","volume":"30","author":"Coustan","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R276","first-page":"1011","article-title":"Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison.","volume":"52","author":"Moore","year":"2007","journal-title":"J Reprod Med"},{"key":"2019041121421313500_R277","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0306-3356(21)00411-8","article-title":"Morphological changes in the utero-placental bed in pregnancy hypertension.","volume":"4","author":"Brosens","year":"1977","journal-title":"Clin Obstet Gynaecol"},{"key":"2019041121421313500_R278","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/humrep\/deh037","article-title":"Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices.","volume":"19","author":"Prefumo","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R279","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/uog.3965","article-title":"Metformin treatment in pregnant women with polycystic ovary syndrome\u2014is reduced complication rate mediated by changes in the uteroplacental circulation?","volume":"29","author":"Salvesen","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2019041121421313500_R280","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jpeds.2006.01.011","article-title":"Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome.","volume":"148","author":"Glueck","year":"2006","journal-title":"J Pediatr"},{"key":"2019041121421313500_R281","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1464-5491.2004.01251.x","article-title":"Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.","volume":"21","author":"Glueck","year":"2004","journal-title":"Diabet Med"},{"key":"2019041121421313500_R282","author":"Bolton","year":"7 2008"},{"key":"2019041121421313500_R283","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R284","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humrep\/12.1.45","article-title":"The embryo versus endometrium controversy revisited as it relates to predicting pregnancy outcome in in-vitro fertilization-embryo transfer cycles.","volume":"12","author":"Schwartz","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-9378(95)90094-2","article-title":"The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome.","volume":"172","author":"Battaglia","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R286","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0015-0282(16)58145-X","article-title":"Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease.","volume":"65","author":"Aleem","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R287","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/13.4.815","article-title":"Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome.","volume":"13","author":"Vrtacnik-Bokal","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R288","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(16)56452-8","article-title":"Midluteal-phase vaginal color Doppler assessment of uterine artery impedance in a subfertile population.","volume":"61","author":"Steer","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R289","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0015-0282(16)58400-3","article-title":"Transvaginal Doppler study of uterine artery blood flow in in vitro fertilization-embryo transfer cycles.","volume":"66","author":"Cacciatore","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R290","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/HUMREP\/11.2.364","article-title":"Comparison of uterine blood flow characteristics between spontaneous and stimulated cycles before embryo transfer.","volume":"11","author":"Tekay","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R291","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/humupd\/3.5.467","article-title":"Doppler ultrasound investigation of uterine and ovarian blood flow in infertility and early pregnancy.","volume":"3","author":"Dickey","year":"1997","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R292","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/humrep\/17.1.190","article-title":"Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss.","volume":"17","author":"Habara","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R293","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/humrep\/dei502","article-title":"The role of endometrial and subendometrial vascularity measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during frozen-thawed embryo transfer cycles.","volume":"21","author":"Ng","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R294","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/humrep\/16.10.2114","article-title":"Colour Doppler analysis of peri-implantation utero-ovarian haemodynamics in women with excessively high oestradiol concentrations after ovarian stimulation.","volume":"16","author":"Basir","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R295","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF01135678","article-title":"Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF).","volume":"7","author":"Gonen","year":"1990","journal-title":"J In Vitro Fert Embryo Transf"},{"key":"2019041121421313500_R296","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0015-0282(16)55855-5","article-title":"Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin.","volume":"59","author":"Dickey","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R297","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0015-0282(00)01493-X","article-title":"Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: a preliminary study.","volume":"74","author":"Yaman","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R298","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0015-0282(97)81509-9","article-title":"Sonographic assessment of endometrial pattern and thickness in patients treated with clomiphene citrate, human menopausal gonadotropins, and intrauterine insemination.","volume":"68","author":"Hock","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R299","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(00)00643-9","article-title":"New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer.","volume":"74","author":"Fanchin","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R300","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00016347309158301","article-title":"Metabolism of glucose in the human endometrium with special reference to fertility and contraception.","volume":"52","author":"Hackl","year":"1973","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041121421313500_R301","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1139\/y87-056","article-title":"Basal, oxytocin- and insulin-stimulated glucose oxidation in human endometrium.","volume":"65","author":"Truchan","year":"1987","journal-title":"Can J Physiol Pharmacol"},{"key":"2019041121421313500_R302","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0015-0282(16)55674-X","article-title":"Tyrosine kinase activity of insulin like growth factor I and insulin receptors in human endometrium during the menstrual cycle: cyclic variation of insulin receptor expression.","volume":"59","author":"Strowitzki","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R303","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1095\/biolreprod65.5.1364","article-title":"Glucose transporter expression in rat embryo and uterus during decidualization, implantation, and early postimplantation.","volume":"65","author":"Korgun","year":"2001","journal-title":"Biol Reprod"},{"key":"2019041121421313500_R304","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/gye.15.3.219.224","article-title":"Expression of glucose transporter 1 in human endometrial and decidual tissue.","volume":"15","author":"Strowitzki","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R305","first-page":"1554","article-title":"Glucose transporter expression and distribution in the human placenta throughout gestation and in intrauterine growth retardation.","volume":"77","author":"Jansson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R306","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1210\/jc.2003-032028","article-title":"Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.","volume":"89","author":"Mioni","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R307","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0015-0282(02)03101-1","article-title":"The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome.","volume":"77","author":"Ajossa","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R308","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod66.2.297","article-title":"Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome.","volume":"66","author":"Apparao","year":"2002","journal-title":"Biol Reprod"},{"key":"2019041121421313500_R309","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/humupd\/6.1.75","article-title":"The role of HOXA genes in human implantation.","volume":"6","author":"Taylor","year":"2000","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1210\/jc.2002-021072","article-title":"Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome.","volume":"88","author":"Cermik","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R311","first-page":"14","article-title":"Endothelin-1 gene expression and protein biosynthesis in human endometrium: potential modulator of endometrial blood flow.","volume":"74","author":"Economos","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R312","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0015-0282(97)81401-X","article-title":"Evidence of interplay between plasma endothelin-1 and 17 \u03b2-estradiol in regulation of uterine blood flow and endometrial growth in infertile women.","volume":"67","author":"Cacciatore","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R313","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.","volume":"89","author":"Orio Jr","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R314","first-page":"332","article-title":"Carcinoma of the endometrium in young women.","volume":"88","author":"Speert","year":"1949","journal-title":"Surg Gynaecol Obstet"},{"key":"2019041121421313500_R315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9378(16)37277-5","article-title":"The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma.","volume":"73","author":"Dockerty","year":"1957","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R316","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovary syndrome and endometrial cancer.","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"key":"2019041121421313500_R317","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia.","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"key":"2019041121421313500_R318","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1038\/sj.onc.1207751","article-title":"Obesity and cancer.","volume":"23","author":"Calle","year":"2004","journal-title":"Oncogene"},{"key":"2019041121421313500_R319","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0029-1211234","article-title":"Estrogen use and cancer risk: a review.","volume":"101","author":"Lupulescu","year":"1993","journal-title":"Exp Clin Endocrinol"},{"key":"2019041121421313500_R320","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.1997.4656","article-title":"Increased expression of LH\/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.","volume":"65","author":"Konishi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"2019041121421313500_R321","first-page":"89","article-title":"Pathological and immunohistochemical study on estrogen and progesterone receptors in endometrium of polycystic ovarian syndrome.","volume":"33","author":"Li","year":"1998","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2019041121421313500_R322","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0015-0282(03)00987-7","article-title":"Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome.","volume":"80","author":"Maliqueo","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R323","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/0002-9378(91)90047-U","article-title":"Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer.","volume":"165","author":"Nagamani","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R324","first-page":"191","article-title":"The nature of hyperinsulinaemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide.","volume":"46","author":"Bershtein","year":"2000","journal-title":"Vopr Onkol"},{"key":"2019041121421313500_R325","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ygyno.2007.02.012","article-title":"Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R\/mannose 6-phosphate) in endometrial adenocarcinoma.","volume":"105","author":"Pavelic\u0301","year":"2007","journal-title":"Gynecol Oncol"},{"key":"2019041121421313500_R326","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","article-title":"A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.","volume":"17","author":"Gunter","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"2019041121421313500_R327","first-page":"i96","article-title":"Endometrial gene expression in women with polycystic ovary syndrome","volume":"20","author":"Pillay","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R328","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ijc.2910590303","article-title":"Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors.","volume":"59","author":"Rutanen","year":"1994","journal-title":"Int J Cancer"},{"key":"2019041121421313500_R329","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent.","volume":"17","author":"Session","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R330","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.","volume":"196","author":"Legro","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R331","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0300-595X(86)80029-9","article-title":"Pilosebaceous physiology in relation to hirsutism and acne.","volume":"15","author":"Rosenfield","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"2019041121421313500_R332","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/humrep\/dem271","article-title":"Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.","volume":"22","author":"Trolle","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R333"},{"key":"2019041121421313500_R334","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.","volume":"90","author":"Ortega-Gonza\u0301lez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09513590400004736","article-title":"Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.","volume":"19","author":"Sahin","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R336","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R337","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/jcem.87.6.8568","article-title":"Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.","volume":"87","author":"Iba\u0301n\u0303ez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R338","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/humupd\/dmi054","article-title":"Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.","volume":"12","author":"Iba\u0301n\u0303ez","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R339","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R340","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/humrep\/deh103","article-title":"Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin.","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R341","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R342","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.0.1470217","article-title":"The effect of metformin on hirsutism in polycystic ovary syndrome.","volume":"147","author":"Kelly","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R343","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R344","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R345","first-page":"884","article-title":"Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study.","volume":"5","author":"Bellot-Rojas","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"2019041121421313500_R346","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2007.03105.x","article-title":"A systematic review of commonly used medical treatments for hirsutism in women.","volume":"68","author":"Koulouri","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R347","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R348","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline.","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R349","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/09513590400021201","article-title":"Polycystic ovary syndrome and gynecological cancers: is there a link?","volume":"20","author":"Gadducci","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568008043339965","article-title":"Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors.","volume":"4","author":"Guastamacchia","year":"2004","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"2019041121421313500_R351","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"2019041121421313500_R352","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.01.007","article-title":"Targeting AMPK: a new therapeutic opportunity in breast cancer.","volume":"67","author":"Hadad","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"2019041121421313500_R353","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20080557","article-title":"Important role of the LKB1-AMPK pathway in suppressing tumourigenesis in PTEN-deficient mice.","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"2019041121421313500_R354","author":"Phoenix","year":"7"},{"key":"2019041121421313500_R355","author":"Stambolic","year":"26 2008"},{"key":"2019041121421313500_R356","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/dmm030","article-title":"Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review.","volume":"14","author":"Jones","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R357","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.2007.02742.x","article-title":"Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers.","volume":"66","author":"Ching","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R358","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/humrep\/del069","article-title":"Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality.","volume":"21","author":"Hahn","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R359","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09513590600604541","article-title":"Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the polycystic ovary syndrome questionnaire (PCOSQ) and the Short Form-36 (SF-36).","volume":"22","author":"Coffey","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R360","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00128071-200708040-00003","article-title":"Dermatologic manifestations of polycystic ovary syndrome.","volume":"8","author":"Lee","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"2019041121421313500_R361","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-992924","article-title":"Mood and sexual function in polycystic ovary syndrome.","volume":"26","author":"Janssen","year":"2008","journal-title":"Semin Reprod Med"},{"key":"2019041121421313500_R362","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/humrep\/deh319","article-title":"An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome.","volume":"19","author":"Wely","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R363","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2005.06426.x","article-title":"A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome.","volume":"152","author":"Clayton","year":"2005","journal-title":"Br J Dermatol"},{"key":"2019041121421313500_R364","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/humrep\/deh048","article-title":"The polycystic ovary syndrome health-related quality of life questionnaire (PCOSQ): a validation.","volume":"19","author":"Jones","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R365","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"consecutive patients.","volume":"89","author":"Azziz","year":"1000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R366","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet.","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R367","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/1464727022000198952","article-title":"Polycystic ovary syndrome and fat distribution: the central issue?","volume":"5","author":"Lord","year":"2002","journal-title":"Hum Fertil (Cambr)"},{"key":"2019041121421313500_R368","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"key":"2019041121421313500_R369","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/gye.16.1.45.51","article-title":"Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome.","volume":"16","author":"Strowitzki","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R370","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome.","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R371","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.ATV.20.8.1932","article-title":"Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study.","volume":"20","author":"Despre\u0301s","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121421313500_R372","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/GCO.0b013e32825e1d70","article-title":"Obesity and reproduction: impact and interventions.","volume":"19","author":"Nelson","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019041121421313500_R373","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R374","first-page":"1617","article-title":"Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.","volume":"84","author":"Imani","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R375","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/humupd\/dmg035","article-title":"Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis.","volume":"9","author":"Mulders","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041121421313500_R376","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/humrep\/deh343","article-title":"Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success.","volume":"19","author":"Amer","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R377","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1471-0528.1989.tb03288.x","article-title":"The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body-weight.","volume":"96","author":"Gj\u00f8nnaess","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041121421313500_R378","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000107291.46159.00","article-title":"Maternal morbid obesity and the risk of adverse pregnancy outcome.","volume":"103","author":"Cedergren","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2019041121421313500_R379","year":"2004"},{"key":"2019041121421313500_R380","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ajcn\/74.5.579","article-title":"Long-term weight-loss maintenance: a meta-analysis of US studies.","volume":"74","author":"Anderson","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"2019041121421313500_R381","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","article-title":"A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.","volume":"81","author":"Stamets","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R382","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dem391","article-title":"Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.","volume":"23","author":"Palomba","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R383","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2165\/00002018-200730120-00005","article-title":"Body weight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.","volume":"30","author":"Hermansen","year":"2007","journal-title":"Drug Saf"},{"key":"2019041121421313500_R384","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2169\/internalmedicine.47.0969","article-title":"Effects of pretreatment with low-dose metformin on metabolic parameters and weight gain by pioglitazone in Japanese patients with type 2 diabetes.","volume":"47","author":"Kawai","year":"2008","journal-title":"Intern Med"},{"key":"2019041121421313500_R385","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2007.07010079","article-title":"Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.","volume":"165","author":"Wu","year":"2008","journal-title":"Am J Psychiatry"},{"key":"2019041121421313500_R386","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2007.56-b","article-title":"Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.","volume":"299","author":"Wu","year":"2008","journal-title":"JAMA"},{"key":"2019041121421313500_R387","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing\u2019s syndrome.","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"},{"key":"2019041121421313500_R388","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2265.2008.03285.x","article-title":"Metformin increases fasting plasma PYY in women with PCOS.","volume":"69","author":"Tsilchorozidou","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R389","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome.","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121421313500_R390","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2265.2008.03204.x","article-title":"Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.","volume":"69","author":"Romualdi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R391","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1463-1326.2008.00857.x","article-title":"Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?","volume":"10","author":"Kusaka","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2019041121421313500_R392","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/dmrr.681","article-title":"Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes.","volume":"23","author":"English","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"2019041121421313500_R393","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/db08-0127","article-title":"Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"2019041121421313500_R394","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/09513590701260193","article-title":"Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.","volume":"23","author":"Nawrocka","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R395","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R396","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R397","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjmed.2007.09.016","article-title":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.","volume":"121","author":"Salpeter","year":"2008","journal-title":"Am J Med"},{"key":"2019041121421313500_R398","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2169\/internalmedicine.47.0787","article-title":"Metformin and parameters of physical health.","volume":"47","author":"Helvaci","year":"2008","journal-title":"Intern Med"},{"key":"2019041121421313500_R399","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","article-title":"Androgens and coronary artery disease.","volume":"24","author":"Wu","year":"2003","journal-title":"Endocr Rev"},{"key":"2019041121421313500_R400","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin.","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr Rev"},{"key":"2019041121421313500_R401","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"2019041121421313500_R402","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehm518","article-title":"The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.","volume":"29","author":"Mellbin","year":"2008","journal-title":"Eur Heart J"},{"key":"2019041121421313500_R403","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"key":"2019041121421313500_R404","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00395-007-0691-y","article-title":"Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.","volume":"103","author":"Bhamra","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"2019041121421313500_R405","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1210\/jc.2006-0216","article-title":"Cardiopulmonary impairment in young women with polycystic ovary syndrome.","volume":"91","author":"Orio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R406","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI118903","article-title":"Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.","volume":"98","author":"Clausen","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041121421313500_R407","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa011858","article-title":"Exercise capacity and mortality among men referred for exercise testing.","volume":"346","author":"Myers","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R408","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2006-2794","article-title":"Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome.","volume":"92","author":"Vigorito","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R409","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1139\/H07-144","article-title":"Impact of metformin on peak aerobic capacity.","volume":"33","author":"Braun","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"2019041121421313500_R410","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R411","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.fertnstert.2006.03.013","article-title":"Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome","volume":"86","author":"Zegher","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121421313500_R412","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1056\/NEJMoa042275","article-title":"Premature birth and later insulin resistance.","volume":"351","author":"Hofman","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R413","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1210\/jc.2004-0918","article-title":"Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys.","volume":"89","author":"Bruns","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R414","first-page":"1206","article-title":"Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys.","volume":"85","author":"Eisner","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R415","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","article-title":"Cardiometabolic features of polycystic ovary syndrome.","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121421313500_R416","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R417","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/diacare.26.4.977","article-title":"Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program.","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R418","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/diacare.25.12.2244","article-title":"Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.","volume":"25","author":"Johnson","year":"2002","journal-title":"Diabetes Care"},{"key":"2019041121421313500_R419","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4158\/EP.13.4.373","article-title":"Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.","volume":"13","author":"Sharma","year":"2007","journal-title":"Endocr Pract"},{"key":"2019041121421313500_R420","first-page":"508","article-title":"Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.","volume":"75","author":"Zimmermann","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R421","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.humrep.a019028","article-title":"Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?","volume":"11","author":"Holte","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R422","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"2019041121421313500_R423","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population.","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R424","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increase in endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin treatment.","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R425","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.HYP.37.5.1199","article-title":"Gender differences in the regulation of blood pressure.","volume":"37","author":"Reckelhoff","year":"2001","journal-title":"Hypertension"},{"key":"2019041121421313500_R426","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/gye.16.6.447.452","article-title":"The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.","volume":"16","author":"Uncu","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R427","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/jc.2006-0399","article-title":"Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome.","volume":"91","author":"Cascella","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R428","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/HJH.0b013e3282f4a13c","article-title":"Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.","volume":"26","author":"Wang","year":"2008","journal-title":"J Hypertens"},{"key":"2019041121421313500_R429"},{"key":"2019041121421313500_R430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2840-7-10","article-title":"Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin\/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).","volume":"7","author":"Komajda","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"2019041121421313500_R431","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1291\/hypres.30.387","article-title":"Blood pressure control and inflammatory markers in type-2 diabetic patients treated with pioglitazone or rosiglitazone and metformin.","volume":"30","author":"Derosa","year":"2007","journal-title":"Hypertens Res"},{"key":"2019041121421313500_R432","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajog.2007.09.014","article-title":"How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?","volume":"198","author":"Rizzo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R433","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00592-008-0032-0","article-title":"Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver.","volume":"45","author":"Tessari","year":"2008","journal-title":"Acta Diabetol"},{"key":"2019041121421313500_R434","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.yexcr.2008.03.002","article-title":"Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line.","volume":"314","author":"Puljak","year":"2008","journal-title":"Exp Cell Res"},{"key":"2019041121421313500_R435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajog.2007.09.013","article-title":"Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint.","volume":"198","author":"Wild","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121421313500_R436","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0038-1657607","article-title":"PAI-1, obesity, insulin resistance and risk of cardiovascular events.","volume":"78","author":"Juhan-Vague","year":"1997","journal-title":"Thromb Haemost"},{"key":"2019041121421313500_R437","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio Jr","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"2019041121421313500_R438","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","article-title":"Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.","volume":"28","author":"Skurk","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121421313500_R439","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2003-38386","article-title":"Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.","volume":"35","author":"He","year":"2003","journal-title":"Horm Metab Res"},{"key":"2019041121421313500_R440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","article-title":"The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.","volume":"81","author":"Ersoy","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041121421313500_R441","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/09513590701666571","article-title":"Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.","volume":"23","author":"Oktenli","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2019041121421313500_R442","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R443","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocyte as a new marker of low grade chronic inflammation and early cardiovascular risk in the polycystic ovary syndrome.","volume":"90","author":"Orio Jr","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R444","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0133","article-title":"Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study.","volume":"157","author":"Orio","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R445","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-07-0815","article-title":"Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.","volume":"158","author":"Lund","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2019041121421313500_R446","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-\u03baB in human vascular wall cells.","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121421313500_R447","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200710-1602OC","article-title":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury.","volume":"178","author":"Zmijewski","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2019041121421313500_R448","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1210\/jc.2004-0436","article-title":"Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.","volume":"89","author":"Dandona","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R449","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/humrep\/dei329","article-title":"Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-\u03b1 and the neutrophil\/lymphocyte ratio.","volume":"21","author":"Iba\u0301n\u0303ez","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R450","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/humrep\/dei072","article-title":"High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.","volume":"20","author":"Iba\u0301n\u0303ez","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R451","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R452","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.AOG.0000296657.41236.10","article-title":"Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.","volume":"111","author":"Battaglia","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2019041121421313500_R453","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metaformin treatment.","volume":"93","author":"Heutling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R454","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/humrep\/den230","article-title":"Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective.","volume":"23","author":"Romualdi","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121421313500_R455","first-page":"196","article-title":"Relationship between tissue culture cytotoxicity and acute toxicity in mice of biguanide derivatives.","volume":"18","author":"Rikimaru","year":"1965","journal-title":"J Antibiot"},{"key":"2019041121421313500_R456","first-page":"566","article-title":"Influence of metformin on vascular cell proliferation.","volume":"14","author":"Koschinsky","year":"1988","journal-title":"Diabetes Metab"},{"key":"2019041121421313500_R457","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.metabol.2006.09.006","article-title":"Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.","volume":"56","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Metabolism"},{"key":"2019041121421313500_R458","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2265.2006.02551.x","article-title":"Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.","volume":"65","author":"Topcu","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121421313500_R459","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"2019041121421313500_R460","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"2019041121421313500_R461","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4158\/EP.14.2.193","article-title":"Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker.","volume":"14","author":"Patel","year":"2008","journal-title":"Endocr Pract"},{"key":"2019041121421313500_R462","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.febslet.2007.11.018","article-title":"Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.","volume":"582","author":"Hardie","year":"2008","journal-title":"FEBS Lett"},{"key":"2019041121421313500_R463","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041121421313500_R464","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fertnstert.2004.08.020","article-title":"Abnormal aminotransferase activity in women with polycystic ovary syndrome.","volume":"83","author":"Schwimmer","year":"2005","journal-title":"Fert Steril"},{"key":"2019041121421313500_R465","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome.","volume":"91","author":"Setji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R466","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.","volume":"47","author":"Cerda","year":"2007","journal-title":"J Hepatol"},{"key":"2019041121421313500_R467","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041121421313500_R468","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.21991","article-title":"High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase.","volume":"47","author":"Adachi","year":"2008","journal-title":"Hepatology"},{"key":"2019041121421313500_R469","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R470","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.21995","article-title":"Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells.","volume":"47","author":"Caligiuri","year":"2008","journal-title":"Hepatology"},{"key":"2019041121421313500_R471","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1665-2681(19)31902-7","article-title":"Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.","volume":"6","author":"Duseja","year":"2007","journal-title":"Ann Hepatol"},{"key":"2019041121421313500_R472","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1742-1241.2008.01825.x","article-title":"The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome.","volume":"62","author":"Preiss","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2019041121421313500_R473","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1872-034X.2007.00215.x","article-title":"Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.","volume":"38","author":"Oliveira","year":"2008","journal-title":"Hepatol Res"},{"key":"2019041121421313500_R474","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2036.2008.03723.x","article-title":"Clinical trial: insulin sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.","volume":"28","author":"Idilman","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041121421313500_R475","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2005-1210","article-title":"Thyrotropin suppression by metformin","volume":"91","author":"Vigersky","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R476","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-007-9012-3","article-title":"Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy.","volume":"32","author":"Isidro","year":"2007","journal-title":"Endocrine"},{"key":"2019041121421313500_R477","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.psyneuen.2007.06.010","article-title":"Cognitive functioning in polycystic ovary syndrome.","volume":"32","author":"Barnard","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"2019041121421313500_R478","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.yhbeh.2007.02.007","article-title":"Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women.","volume":"51","author":"Schattmann","year":"2007","journal-title":"Horm Behav"},{"key":"2019041121421313500_R479","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.yhbeh.2007.02.002","article-title":"Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study.","volume":"51","author":"Schattmann","year":"2007","journal-title":"Horm Behav"},{"key":"2019041121421313500_R480","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jc.2005-1084","article-title":"Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.","volume":"91","author":"Tasali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R481","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.smrv.2005.01.006","article-title":"Sleep apnea is a manifestation of the metabolic syndrome.","volume":"9","author":"Vgontzas","year":"2005","journal-title":"Sleep Med Rev"},{"key":"2019041121421313500_R482","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.","volume":"144","author":"Iba\u0301n\u0303ez","year":"2004","journal-title":"J Pediatr"},{"key":"2019041121421313500_R483","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2004-0463","article-title":"Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.","volume":"89","author":"Iba\u0301n\u0303ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121421313500_R484"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/30\/1\/1\/8862411\/edrv0001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T02:53:34Z","timestamp":1710039214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/30\/1\/1\/2354986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,4]]},"references-count":484,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,12,4]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2008-0030","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,4]]}}}